A trio of historically cheap, supercharged income stocks can pad the pocketbooks of patient investors.

This article features deals sourced directly by Gizmodo and produced independently of the editorial team. We may earn a commission when you buy through links on the site. Reading time 3 minutes If you ...

PepsiCo, an American multinational food, snack, and beverage corporation, is now a $191 billion (by market cap) snack and beverage giant. PEP increased its dividend for a whopping 53 consecutive years ...

Healthcare may be entering early mean reversion, but much of Johnson & Johnson’s valuation recovery has already occurred. Post-Kenvue, JNJ is a higher-growth, less dividend-centric business, changing ...

David Harrell: Hi, I’m David Harrell, editor of the Morningstar DividendInvestor Newsletter. And I’m joined once again by Dave Sekera, who is Morningstar’s Chief US Market Strategist. Dave, thanks for ...